Gyre Therapeutics, Inc. · NASDAQ:GYRE
Ye Weiguo sold 2,800 Gyre Therapeutics, Inc. shares (Form 4)
Traded Jun 11, 2026 · Filed Jun 15, 2026
On Jun 11, 2026, Ye Weiguo (Chief Operating Officer) sold 2,800 Gyre Therapeutics, Inc. shares at US$6.17 for US$17,276, leaving 700,000 shares. Filed Jun 15, 2026 (Form 4).
- Sold
- 2,800 shares
- Price
- US$6.17
- Value
- US$17,276
- Holding after
- 700,000 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock | Option exercise | 2,800 | US$0.75 | 702,800 | Direct |
| Jun 11, 2026 | Common Stock | Sale | 2,800 | US$6.17 | 700,000 | Direct |
Source
Related
- Gyre Therapeutics, Inc.
- Ye Weiguo
- Gyre Therapeutics, Inc. shareholders
- Form 4 · Ye Weiguo · Jun 22, 2026
- Form 4 · Ye Weiguo · Jun 11, 2026
- Form 4 · Ye Weiguo · Jun 8, 2026
- Form 4 · Ye Weiguo · May 27, 2026
- Form 4 · Ye Weiguo · May 22, 2026
- Form 4 · Ye Weiguo · May 20, 2026
- Form 4 · Ye Weiguo · May 18, 2026
- Form 4 · Luo Ying · May 7, 2026
- Schedule 13D/A · Songjiang Ma · May 7, 2026
- Schedule 13D/A · GNI Group Ltd. · May 6, 2026